Basics Dyne Therapeutics, Inc. IPO Date: September 17, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.33B Activated in VL: True Average Daily Range Avg Daily Range: $0.52 | 3.27% Avg Daily Range (30 D): $0.44 | 4.02% Avg Daily Range (90 D): $0.42 | 3.79% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): 2.32M Avg Daily Volume (90 D): 1.92M Trade Size Avg Trade Size (Sh.): 83 Avg Trade Size (Sh.) (30 D): 91 Avg Trade Size (Sh.) (90 D): 92 Institutional Trades Total Inst.Trades: 1,616 Avg Inst. Trade: $2.62M Avg Inst. Trade (30 D): $1.45M Avg Inst. Trade (90 D): $2.72M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.12M Avg Closing Trade (30 D): $2.28M Avg Closing Trade (90 D): $3.66M Avg Closing Volume: 196.91K     News Mar 16, 2025 @ 11:00 PM Dyne Therapeutics Announces New Long-Term Clinical... Source: N/A Jun 24, 2024 @ 11:30 AM Dyne Therapeutics Presents New Preclinical Data De... Source: Dyne Therapeutics, Inc. Jun 13, 2024 @ 8:40 PM Dyne Therapeutics Presents New Preclinical Data fo... Source: Dyne Therapeutics, Inc. Jun 12, 2024 @ 2:09 PM Soft Inflation Data Boosts Small Caps, Real Estate... Source: Piero Cingari May 30, 2024 @ 11:30 AM Dyne Therapeutics to Present at Jefferies Global H... Source: Dyne Therapeutics, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.59 $-1.05 $-.88 Diluted EPS $-3.59 $-1.05 $-.88 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -367.13M $ -115.36M $ -89.54M Operating Income / Loss $ -397.1M $ -122.37M $ -97.11M Cost of Revenue $ $ $ Net Cash Flow $ 200.24M $ 36.81M $ -96.71M PE Ratio